Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neovasculgen in Painful Bladder Syndrome/Interstitial Cystitis With Hunner's Lesions
NCT07459790Phase 3Recruiting
- Sponsor
- NextGen
- Start
- Dec 2023
- Primary completion
- Oct 2027
- Modality
- Gene Editing, Gene Silencing, Plasmid DNA
- Countries
- 1
01
Overview
A Phase 3 trial of neovasculgen in interstitial cystitis (IC), bladder pain syndrome (BPS), sponsored by NextGen. Started Dec 2023; status: recruiting.
02
Drugs
neovasculgen
03
Conditions
interstitial cystitis (IC)bladder pain syndrome (BPS)
Beyond the preview
Go deeper on NCT07459790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07459790.